RE: Leaky Leaky29 Jul 2020 11:10
hamsters18
more buyers returning to covid shares again
also with the £millions ncyt now have coming in each month
and people seeing how ncyt using some of money
R&D highlights
· Launch of near-patient (mobile) testing, which comprises Novacyt's COVID-19 test, direct-to-PCR RNA extraction kit (Exsig™ Direct), and q16 and q32 instruments
· Launch of a saliva sampling type to support ease of patient sampling, lower levels of discomfort and demonstrate more reproducible data
· Development of a respiratory testing panel to diagnose and distinguish between influenza A&B, RSV and COVID-19. Launch expected during September 2020 for the 2020/21 flu season in the Northern hemisphere
· Development of a two-gene test to address markets employing this testing approach. Launch expected no later than September 2020
· Development, together with a partner, of a serology (antibody) test to detect past infection of COVID-19. Launch expected in Q4 2020
also people now watching for some of rns to be released